⏱️12 min read | Unique research highlights an overlooked mental health disparity among Indigenous North American people with HD - and the need for care grounded in trust, community partnership, and cultural understanding.

Skyhawk shared data at the 15 month mark for SKY-0515 treatment in people with HD in their Phase 1/2 trial. The drug is working as designed and there are some encouraging signs that it could be helpful for some symptoms of HD. 

⏱️8 min read | What if nutrition is one of the warning lights we should be checking earlier in Huntington’s disease? New research suggests simple nutrition measures may help identify when people with HD need extra support.